J Ludvigsson, M Faresjo, M Hjorth, S … - The New England journal of medicine, 2008 - nejm.highwire.org Results Insulin secretion gradually decreased in both study groups. The study
treatment had no significant effect on change in fasting C-peptide level after
15 months (the primary end point). Fasting C-peptide levels declined from ... Cited by 32 - Related articles - All 7 versions
J Ludvigsson - Diabetes/Metabolism Research and Reviews, 2009 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Related articles - All 2 versions
KC Herold, S Gitelman, C Greenbaum, J Puck, … - Clinical Immunology, 2009 - Elsevier Anti-CD3 mAbs may prolong β cell function up to 2 years in patients with new
onset Type 1 diabetes (T1DM). A randomized open label trial of anti-CD3 mAb,
Teplizumab, in T1DM was stopped after 10 subjects because of increased ... Cited by 2 - Related articles - All 2 versions
[CITATION] Challenges in developing endpoints for type 1 diabetes intervention studies Updated …
S Cernea, I Raz, KC Herold, B Hirshberg, BO … - Diabetes/Metabolism Research and Reviews, 2009 - John Wiley & Sons, Ltd. Chichester, UK
… , B Keymeulen, K Decochez, I Weets, C De … - Diabetologia - Springer Abstract Aims/hypothesis The aim of the study was to investigate the use of
hyperglycaemic clamp tests to identify individuals who will develop diabetes
among insulinoma-associated protein-2 antibody (IA-2A)-positive ...
J Ludvigsson - Diabetes/Metabolism Reviews - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
KM Dungan, JB Buse, RE Ratner - Diabetes/Metabolism Research and Reviews, 2009 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Related articles - All 2 versions